Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →25
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,013
Total Claims
$1.3M
Drug Cost
772
Beneficiaries
$1,740
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+175%
Opioid rate vs peers
55.6% vs 20.2% avg
+282%
Cost per patient vs peers
$1,740 vs $455 avg
+235%
Brand preference vs peers
10.5% vs 3.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
55.6%
Opioid Rate
6,120
Opioid Claims
$605K
Opioid Cost
27.5%
Long-Acting Rate
This provider's opioid prescribing rate of 55.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,159 claims · $809K
Generic: 9,854 claims · $534K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 180 | $169K |
| Linaclotide | 141 | $139K |
| Oxycodone Hcl | 141 | $129K |
| Buprenorphine Hcl/Naloxone Hcl | 494 | $116K |
| Ubrogepant | 23 | $70K |
| Oxycodone Hcl/Acetaminophen | 1,432 | $68K |
| Naloxegol Oxalate | 108 | $51K |
| Buprenorphine | 133 | $38K |
| Icosapent Ethyl | 86 | $37K |
| Hydrocodone/Acetaminophen | 1,131 | $36K |
| Methylnaltrexone Bromide | 14 | $36K |
| Morphine Sulfate | 858 | $32K |
| Atogepant | 15 | $30K |
| Rimegepant Sulfate | 17 | $28K |
| Oxycodone Hcl | 951 | $25K |
Prescribing Profile
Patient Profile
70
Avg Age
58%
Female
2.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data